Bid Publish Date
29-Jan-2025, 11:24 am
Bid End Date
20-Feb-2025, 11:00 am
Location
Progress
Quantity
52242
Category
Betamethasone plus Gentamycin Oint
Bid Type
Two Packet Bid
Public procurement opportunity for Indian Army Betamethasone plus Gentamycin Oint, Lansoprazole 15mg cap, Isotretinoin 10mg Tab, Inj Pheniramine 22. 75 mg ml, Dicyclomine 20 plus Paracetamol 500mg Tab, Serratiopeptidase 10mg Tab in CENTRAL DELHI, DELHI. Quantity: 52242 issued by. Submission Deadline: 20-02-2025 11: 00: 00. View full details and respond.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Betamethasone plus Gentamycin Oint , Lansoprazole 15mg cap , Isotretinoin 10mg Tab , Inj Pheniramine 22.75 mg ml , Dicyclomine 20 plus Paracetamol 500mg Tab , Serratiopeptidase 10mg Tab
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Betamethasone plus Gentamycin Oint
Betamethasone + Gentamycin Oint
Lansoprazole 15mg cap
Lansoprazole 15mg cap
Isotretinoin 10mg Tab
Isotretinoin 10mg Tab
Inj Pheniramine 22.75 mg ml
Inj Pheniramine 22.75 mg/ml
Dicyclomine 20 plus Paracetamol 500mg Tab
Dicyclomine 20 + Paracetamol 500mg Tab
Serratiopeptidase 10mg Tab
Serratiopeptidase 10mg Tab
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Betamethasone plus Gentamycin Oint | Betamethasone + Gentamycin Oint | 1,230 | tube | [email protected] | 15 | |
| 2 | Lansoprazole 15mg cap | Lansoprazole 15mg cap | 1,500 | no | [email protected] | 15 | |
| 3 | Isotretinoin 10mg Tab | Isotretinoin 10mg Tab | 6,000 | no | [email protected] | 15 | |
| 4 | Inj Pheniramine 22.75 mg ml | Inj Pheniramine 22.75 mg/ml | 12 | amp | [email protected] | 15 | |
| 5 | Dicyclomine 20 plus Paracetamol 500mg Tab | Dicyclomine 20 + Paracetamol 500mg Tab | 7,500 | no | [email protected] | 15 | |
| 6 | Serratiopeptidase 10mg Tab | Serratiopeptidase 10mg Tab | 36,000 | no | [email protected] | 15 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Key insights about DELHI tender market
The eligibility requirements include being a registered entity, demonstrating relevant experience in the pharmaceutical field, and meeting financial criteria. Potential bidders must provide documentation demonstrating their past performance and turnover. Exemption claims regarding experience criteria require additional supporting documentation.
Bidders are required to submit compliance certifications with pharmaceutical standards, OEM authorization certificates, and certifications addressing past performance. Additionally, supporting documents justifying exemption claims must be furnished if applicable.
Interested bidders must register on the designated governmental procurement platform. Once registered, they must ensure the completion of their profile with all relevant documentation. All required certificates and compliance documentation should be prepared for submission before the deadline.
Documents submitted must be in standard formats such as PDF or Word, ensuring clarity and accessibility. Bidders should avoid unconventional formats to prevent submission issues and ensure compliance with tender requirements.
Bidders selected for this tender are typically required to submit a performance security that is a percentage of the total contract value. Payment terms, including the conditions surrounding the performance security, will be specified in the tender documentation. It is crucial for bidders to review these financial requirements thoroughly for compliance.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS